Hudson Bay Capital Management’s Sutro Biopharma STRO Stock Holding History

Hudson Bay Capital Management’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$368K	Buy	+14,768	New	+$267K	﹤0.01%	1013
2025 Q3	–	Sell	-2,257	Closed	-$16.1K	–	1653
2025 Q2	$16.1K	Buy	+2,257	New	+$18.5K	﹤0.01%	1321
2024 Q3	–	Sell	-6,076	Closed	-$178K	–	1034
2024 Q2	$178K	Buy	+6,076	New	+$240K	﹤0.01%	666
2022 Q1	–	Sell	-10,150	Closed	-$1.51M	–	1310
2021 Q4	$1.51M	Buy	10,150 +5,150	+103%	+$923K	0.02%	732
2021 Q3	$945K	Buy	5,000 +2,500	+100%	+$475K	0.01%	761
2021 Q2	$465K	Buy	+2,500	New	+$489K	0.01%	798

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Hudson Bay Capital Management's STRO Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Sutro Biopharma (STRO) in Q1 2026: 14,768 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #1013 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in STRO as recently as Q2 2025.

Hudson Bay Capital Management first reported a position in STRO in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.51M in Q4 2021. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

Hudson Bay Capital Management held 14,768 shares of Sutro Biopharma worth $368K as of Q1 2026.
Sutro Biopharma was a new Hudson Bay Capital Management position in Q1 2026.
Sutro Biopharma made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1013 holding.
Hudson Bay Capital Management first reported a position in Sutro Biopharma in Q2 2021 and has held it in 6 quarters since.
Hudson Bay Capital Management's Sutro Biopharma position peaked at $1.51M in Q4 2021.
78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.